Binding of C-reactive protein (CRP) by human peripheral blood lymphocytes in vivo

G Lozański1, T Pawłowski, P Błazczak

  • 1Department of Immunology and Rheumatology, University School of Medicine, Poznań.

Insights

C-reactive protein (CRP) exists on human lymphocytes in two forms: cell-produced (s-CRP) and bound (sb-CRP). Rheumatoid arthritis patients show increased s-CRP, suggesting distinct lymphocyte interactions with this inflammatory marker.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • C-reactive protein (CRP) is a key inflammatory marker.
  • The presence and function of CRP on lymphocyte surfaces are not fully understood.

Purpose of the Study:

  • To investigate the antigenicity and forms of C-reactive protein (CRP) on human lymphocyte surfaces.
  • To differentiate between lymphocyte-produced CRP and CRP bound to lymphocytes.

Main Methods:

  • Indirect immunofluorescence technique was employed.
  • Anti-CRP antibodies were used to detect CRP on lymphocytes.
  • Lymphocytes from healthy donors and rheumatoid arthritis patients were analyzed.

Main Results:

  • Two forms of surface-bound CRP (sd-CRP) were identified: lymphocyte-produced (s-CRP) and calcium-dependent bound CRP (sb-CRP).
  • In healthy donors, 2.5% of lymphocytes expressed s-CRP and 1.5% expressed sb-CRP.
  • Rheumatoid arthritis patients showed an increase in s-CRP lymphocytes, while sb-CRP levels remained stable unless serum CRP exceeded 50 µg/ml.

Conclusions:

  • CRP is present on distinct lymphocyte populations.
  • Lymphocytes possess specific membrane receptors for CRP binding.
  • Increased s-CRP on lymphocytes may indicate an active inflammatory response in conditions like rheumatoid arthritis.